The role ofglutathione and cytochrome P-450 in the production of DNA damage by chromium(VI) was examined In chicken embryo hepatocytes by the alkaline elution technique. Cellular levels of glutathione and cytochrome P-450 were altered by treating the hepatocytes with N-acetyl-Lcysteine, buthionine sulfoximine, isopentanol, or 8-naphthoflavone. A dramatic increase in chromium(VI)-induced DNA strand breaks was observed after increasing glutathione levels in the cells. Chromium(VI)-induced DNA strand breaks were even more numerous when the level of cytochrome P-450 was also increased. Upon depletion of glutathione levels and induction ofcytochrome P-450 or cytochrome P 448, little or no DNA strand breaks or DNA interstrand cross-links were observed after chromium(VI) treatment. Chromium(VI)-induced DNA-protein cross-links generally decreased after either increases or decreases in cellular levels of glutathione or cytochrome P-450 or P-448. These results suggest that glutathione enhances chromium(VI)-induced DNA damage through metabolic activation of chromium(VI). The possible production of reactive chromium species upon metabolism by glutathione and cytochrome P-450 or P448 and their involvement in DNA damage is discussed.
Chromium(VI) compounds are recognized as carcinogens in humans and animals (1) and as mutagens in bacterial and mammalian cell systems (2) . Chromium(VI) causes DNA strand breaks and cross-links in vivo and in cultured cells (3) (4) (5) (6) . It has been proposed that cellular metabolism of chromium(VI) compounds is necessary for DNA damage, since chromium(VI) does not react with isolated DNA under physiological conditions (7) . The DNA-damaging ability of other carcinogenic agents has been shown to be modulated by metabolic pathways such as the cytochrome P450 system, sulfotransferases, and glutathione (GSH) (8) . Changes in cellular levels of cytochromes P-450 alter the levels of DNA damage produced by carbon tetrachloride (9) , benzo- [a]pyrene (10) , and dimethylnitrosamine (11) 
in rodents.
In vitro studies have identified several cellular components that are capable of metabolizing chromium(VI) (12) (13) (14) . Rat liver microsomes contain a NADPH-dependent chromium(VI) reductase activity (15) . Induction of cytochrome(s) P-450 by phenobarbital enhances the chromium(VI) reductase activity ofliver microsomes; however, induction of cytochrome(s) P-448 by 3-methylcholanthrene has no effect (13) . GSH also reduced chromium(VI) in vitro under physiological conditions (12, 14) . The reaction of GSH with chromium(VI) has been proposed to occur by a two-step mechanism that involves the rapid formation of a chromium(VI) thioester followed by the reduction of the chromium(VI) thioester to chromium(III) (12) .
The present report describes the effect of altering the intracellular concentrations of cytochrome P450 and P-448 and GSH on chromium(VI)-induced DNA damage in primary cultured chicken embryo hepatocytes. Chromium(VI) treatment is known to produce DNA damage in chicken embryo hepatocytes (5, 6) . The hepatocytes are well suited for these experiments because intracellular levels of the different isozymes of cytochrome P-450 can be increased by f naphthoflavone (16) and isopentanol (17) . GSH has been shown to increase in these cells with the induction of cytochrome P-450, but not with induction of cytochrome P-448 (18) . Also, GSH can be decreased in chicken embryo hepatocytes by buthionine sulfoximine (18) or increased by N-acetyl-L-cysteine (see below). The present report shows that changes in cellular levels of cytochrome P-450 or P-448 and GSH in the hepatocytes resulted in dramatic alterations of the levels and types of chromium(VI)-induced DNA lesions detected by the alkaline elution technique. tTo whom reprint requests should be addressed.
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tivity and this inhibition is removed by changing the medium (J. Sinclair, personal communication). Alkaline Elution. After sodium chromate treatment, the hepatocytes were analyzed for DNA damage by using the alkaline elution technique based on the procedure of Kohn et al. (19) as described previously (6) . The alkaline elution technique measures the size distribution of long singlestranded DNA, assuming that the rate of elution of the DNA from a polyvinylchloride filter depends on the length of the DNA and is altered by filter absorption of proteins linked to the DNA (19) . DNA lesions were calculated from the DNA remaining on the filter after 9 hr of elution, by using the equations of Kohn et al. (19) , and were based on the comparison of DNA elution rates of control and treated cells (with or without x-irradiation).
Assays for Cytochromes P-450. Cytochromes P-450 and P-448 were determined by the CO difference spectral assay (20) . Benzphetamine-N-demethylase and 7-ethoxyresorufin-O-deethylase activities, which are assays of cytochrome P-450 and cytochrome P-448 isozymes, respectively, were measured spectrofluorometrically in cell homogenates as described previously (21) .
GSH Assay. GSH was determined spectrofluorometrically according to Hissin and Hilf (22) as described previously (6) . Up to 0.1 mM N-acetyl-L-cysteine did not interfere with this assay.
Sodium Chromate Uptake. The uptake of chromium(VI) by the hepatocytes was determined by analyzing the concentration of 51Cr remaining in the medium after a 2-hr treatment with 5 ,uM sodium [51Cr]chromate (1 ,uCi/,ug).
Statistical Analysis. The Student t test was used for statistical analysis (23) .
RESULTS
Alterations of Cellular GSH and Cytochrome P-450 Levels. The effects of the various drug treatments on GSH and cytochrome P-450 levels and activities in chicken embryo hepatocytes are presented in Table 1 . Since the cytochrome P-450 level does not provide information on the specific forms of cytochrome P-450 present, benzphetamine demethylase and ethoxyresorufln deethylase activities, which are specific for phenobarbital-and 3-methylcholanthrene-inducible isozymes, respectively, were determined. None of the drug treatments changed the total amount of protein found in the hepatocytes (0.40 ± 0.02 mg of protein per 106 cells). After N-acetyl-L-cysteine treatment, GSH was increased 80% while the cytochrome P450 concentration and benzphetamine demethylase activity were unchanged. The apparent decrease in ethoxyresorufin deethylase activity was probably not significant since the levels in all treatments except for f-naphthoflavone were close to the detection limit (0.5 pmol of resorufin per mg of protein per min). Buthionine sulfoximine treatment caused an 85% decrease in GSH levels with no significant effect on cytochrome P-450 level or activities. Since buthionine sulfoximine did not lower and N-acetyl-L-cysteine did not increase benzphetamine demethylase activity, cytochrome P-450 activity did not depend on GSH concentration. Treatment ofthe hepatocytes with isopentanol resulted in a 3.5-fold increase in cytoc';,-ome P-450, associated with a 2-fold increase in benzphetamine demethylase activity, and was accompanied by an 80% increase in GSH. The combined treatment of isopentanol + buthionine sulfoximine increased cytochrome P-450 3.5-fold and benzphetamine demethylase activity 2-fold and decreased GSH 90%. After ,B-naphthoflavone treatment, cytochrome P-448 was increased 2.5-fold with a 36-fold increase in ethoxyresorufin deethylase activity without a significant increase in benzphetamine demethylase activity (P > 0.05) and GSH was decreased by 20% (P < 0.05). The combined treatment of p-naphthoflavone + buthionine sulfoximine increased cytochrome P-448 2-fold and ethoxyresorufin activity 40-fold without any significant increase in benzphetamine demethylase activity (P > 0.05) and it decreased GSH 85% (P < 0.001). GSH concentration did not affect induced cytochrome P-450 activities since addition of buthionine sulfoximine to the inducers isopentanol and ,B-naphthoflavone did not affect the benzphetamine demethylase or ethoxyresorufin deethylase activity. Addition of 5 ,M sodium chromate for 2 hr after treatment of the hepatocytes with the various drugs did not change GSH or cytochrome P-450 levels or activities (P > 0.05). After ,3-naphthoflavone treatment, there was a 20% increase in cytochrome P-448; however, there was no significant change in ethoxyresorufin deethylase activity. Proc. Natl. Acad. Sci. USA 82 (1985) Sodium Chromate-Induced DNA Strand Breaks. Treatment of chicken embryo hepatocytes with 5 AM sodium chromate for 2 hr resulted in 100 rad equivalents (1 rad = 0.01 gray) of DNA strand breaks in the absence of proteinase K digestion (Fig. 1) . Upon proteinase K digestion of cell lysates, 140 rad equivalents of protein-associated DNA strand breaks was observed. Pretreatment of the hepatocytes with N-acetyl-Lcysteine, increasing GSH 80% with no change in cytochrome P-450, was accompanied by a 50-80% increase in chromium(VI)-induced DNA strand breaks (with or without proteinase K). Isopentanol, which increased GSH 80% and increased cytochrome P-450 3.5-fold, resulted in an approximately 140-170% increase in DNA strand breaks (with or without proteinase K) caused by chromium(VI). After isopentanol pretreatment the level of chromium(VI)-induced strand breaks (with or without proteinase K) was 50-60% greater than after N-acetyl-L-cysteine pretreatment (P < 0.02). Depletion of GSH with either an increase (isopentanol + buthionine sulfoximine treatment) or no change (buthionine sulfoximine treatment) in cytochrome P450 decreased chromium(VI)-induced strand breaks approximately 50-75% and completely eliminated protein-associated DNA strand breaks. There was no significant difference between the chromium(VI)-induced DNA strand breaks seen with buthionine sulfoximine or buthionine sulfoximine + isopentanol pretreatments (P > 0.1). Pretreatment of hepatocytes with 83-naphthoflavone, which caused a 20% decrease in GSH as well as a 2.5-fold increase in cytochrome P-448, resulted in a 50-85% decrease in DNA strand breaks caused by chromium(VI) and eliminated protein-associated DNA strand breaks. Chromium(VI)-induced DNA strand breaks were absent after the combined treatment of /3-naphthoflavone + buthionine sulfoximine. This value was significantly less than for buthionine sulfoximine or ,Bnaphthoflavone pretreatment alone (P < 0.01).
Sodium Chromate-Induced DNA Cross-Links. 2 . DNA cross-links in chicken embryo hepatocytes produced by chromium(VI) after various drug treatments. Cells were treated as described in Fig. 1 legend. Open bars, total DNA cross-links (without proteinase K digestion); cross-hatched bars, DNA interstrand cross-links (with proteinase K digestion of the cell lysates). Values represent mean ± SEM for n -6. *P < 0.01 vs. no drug treatment. tP < 0.005 vs. no drug treatment.
cytochrome P-450 and GSH than were DNA strand breaks (Fig. 2) . DNA interstrand cross-links were not significantly (P > 0.05) affected by changes in either cytochrome P-450 or GSH levels except after the combined pretreatment with /3-naphthoflavone + buthionine sulfoximine or isopentanol + buthionine sulfoximine, which resulted in elimination of DNA interstrand cross-links (P < 0.01). After isopentanol pretreatment, the level of chromium(VI)-induced DNA interstrand cross-links was greater than after N-acetyl-Lcysteine pretreatment (P < 0.05). Chromium(VI)-induced total DNA cross-links (mainly DNA-protein cross-links) were reduced approximately 50% (P < 0.005) by all the drug treatments except isopentanol alone, with which no change (P > 0.05) was observed.
Effect ofDrug Treatments on Chromate Uptake. The uptake of sodium chromate was measured after the various drug treatments to ensure that the changes in chromium(VI)-induced DNA damage were not due to changes in chromium(VI) uptake by the hepatocytes ( Cells were treated and analyzed for DNA damage by using alkaline elution. Calculations of DNA damage compared untreated cells with drug-treated cells. All values represent mean ± SEM for n : 6. *P < 0.05 vs. zero. chromium(VI) treatment was always compared to drug treatment alone to eliminate any possible low level of DNA damage resulting from the drug treatments from the data.
DISCUSSION
The level of chromium(VI)-induced DNA strand breaks was dramatically increased in hepatocytes with increased levels of GSH (N-acetyl-L-cysteine and isopentanol pretreatments) and dramatically decreased with decreased levels of GSH (buthionine sulfoximine and f3-naphthoflavone pretreatments) (Fig. 1) . Increased levels of protein-associated DNA strand breaks were observed only with treatments (N-acetyl-L-cysteine and isopentanol) that increased GSH levels. Protein-associated strand breaks may be due to chromium(VI)-induced DNA-protein cross-links or to covalent attachment of repair enzymes, topoisomerases, or other nuclear proteins to sites of DNA strand breakage (24) . These results suggest that GSH played a key role in the activation of chromium(VI) to species capable of causing DNA strand breaks. Although GSH is usually thought to protect cells from the toxic effects of agents such as acetaminophen (25) , benzo[a]pyrene (26) , and radiation (27) , it is also known to activate mutagens such as N-hydroxy-3-amino-1-methyl-5H-pyrido [4,3-b] indole (28) , 1,2-dibromoethane (29, 30 ), 1,2-dichloroethane (31) , N-methyl-and N-ethyl-N'-nitro-N-nitrosoguanidine (29) . GSH has been shown to be important for reduction of chromium(VI) in rat liver in vivo (14) . GSH has been shown to form a chromium(VI) thioester upon reaction with chromium(VI) in vitro (12, 32) . It is possible that formation of a chromium(VI) thioester in cells could aid in the cellular activation of chromium(VI). The chromium(VI) thioester of GSH has been shown to undergo a redox reaction involving GSH in vitro, producing reactive chromium(IV) species (12) that may be capable of damaging DNA (Fig. 3) . Even though no change in GSH level was observed after chromium(VI) treatment, the steady-state amount of the chromium(VI) thioester in the cells is expected to be small (12) , so the detection of any small change in GSH levels is unlikely. Also, previous studies have shown that chromium(VI) stimulates the synthesis of GSH in chicken embryo hepatocytes (6) .
GSH was not the only cellular metabolic system involved in chromium(VI)-induced DNA damage. Induction of cytochromes P-450 and P-448 also altered chromium(VI)-induced DNA damage ( Figs. 1 and 2 ). In the presence of high levels of GSH, isopentanol-induced cytochrome P450 appeared to act synergistically with GSH and to increase the chromium(VI)-induced DNA strand breaks (P < 0.01) and DNA interstrand cross-links (P < 0.1). In the presence of GSH, the level of chromium(VI)-induced DNA strand breaks decreased after induction of cytochrome P-448 by ,Bnaphthoflavone. This could be due to the cytochrome P-448 deactivating the chromium(VI) or could be related to the 20% decrease in GSH found upon /3-naphthoflavone treatment. These results were similar to those observed with chromium(VI)-induced DNA strand breaks.
Total DNA cross-links (mainly DNA-protein cross-links) produced by chromium(VI) were not significantly changed by the isopentanol pretreatment (high cytochrome P-450 with high GSH). Both an increase and a decrease in GSH without any change in cytochrome P-450 or P-448 resulted in a 40% decrease in chromium(VI)-induced DNA-protein cross-links. It appeared that DNA-protein cross-links may be formed by a different mechanism than DNA strand breaks or DNA interstrand cross-links. Chromium(V) intermediates or chromium(III) complexes formed as the final products of metabolism may be responsible for the formation of DNAprotein cross-links. It is possible that other cellular components such as GSH transferases may be involved in producing some chromium(VI)-induced DNA lesions. Along with GSH, GSH transferases have been shown to be important for the formation of DNA adducts with 1,2-dibromoethane (30) and N-hydroxy-3-amino-1-methyl-5H-pyrido [4,3-b] indole (28) .
GSH transferases are altered in rats by 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment (10) . Another complication with the chromium(VI)-induced DNAprotein cross-links was that the level of cross-links might have been rising at the time examined. Previous work with chicken embryo hepatocytes has shown that chromium(VI)-induced DNA-protein cross-links reached a maximal level 3 hr after removal of chromium(VI) following a 2-hr treatment with 5 ptM chromium(VI) (6) . In contrast, DNA interstrand cross-links and strand breaks are maximal immediately after the 2-hr chromium(VI) treatment (6) .
In conclusion, certain forms of cytochrome P-450 in the presence of GSH appeared to activate chromium(VI) to species capable of producing DNA strand breaks and DNA interstrand cross-links. However, upon depletion of GSH and induction of cytochrome P-450 or P448 little or no chromium(VI)-induced DNA strand breaks or interstrand cross-links were observed. These studies indicate that GSH might play a key role in chromium(VI) metabolism and chromium(VI)-induced DNA damage, possibly through the formation of a chromium(VI) thioester. Chromium(VI)-induced DNA-protein cross-links were decreased upon induction or depletion ofGSH and were unchanged by cytochrome P-450 in the presence of GSH, suggesting that these lesions may be formed by a different mechanism than DNA strand breaks and interstrand cross-links.
